Creades AB Series A (0QI9) - Total Liabilities
Based on the latest financial reports, Creades AB Series A (0QI9) has total liabilities worth Skr95.00 Million SEK (≈ $10.22 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Creades AB Series A generate cash to assess how effectively this company generates cash.
Creades AB Series A - Total Liabilities Trend (2012–2025)
This chart illustrates how Creades AB Series A's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Creades AB Series A's assets to evaluate the company's liquid asset resilience ratio.
Creades AB Series A Competitors by Total Liabilities
The table below lists competitors of Creades AB Series A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dana Brata Luhur PT
JK:TEBE
|
Indonesia | Rp63.74 Billion |
|
Triple i Logistics Public Company Limited
BK:III
|
Thailand | ฿1.01 Billion |
|
Charlton Aria Acquisition Corporation Class A Ordinary Shares
NASDAQ:CHAR
|
USA | $1.74 Million |
|
Alkindo Naratama Tbk
JK:ALDO
|
Indonesia | Rp990.37 Billion |
|
Heranba Industries Limited
NSE:HERANBA
|
India | Rs13.33 Billion |
|
Dharmaj Crop Guard Limited
NSE:DHARMAJ
|
India | Rs5.12 Billion |
|
Kyobo With Special Purpose Acq
KQ:205100
|
Korea | ₩9.30 Billion |
|
Urbas Grupo Financiero SA
MC:UBS
|
Spain | €415.90 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Creades AB Series A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Creades AB Series A.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Creades AB Series A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Creades AB Series A (2012–2025)
The table below shows the annual total liabilities of Creades AB Series A from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr95.00 Million ≈ $10.22 Million |
-37.91% |
| 2024-12-31 | Skr153.00 Million ≈ $16.47 Million |
+4.08% |
| 2023-12-31 | Skr147.00 Million ≈ $15.82 Million |
-40.00% |
| 2022-12-31 | Skr245.00 Million ≈ $26.37 Million |
-57.39% |
| 2021-12-31 | Skr575.00 Million ≈ $61.88 Million |
+47.81% |
| 2020-12-31 | Skr389.00 Million ≈ $41.86 Million |
+764.44% |
| 2019-12-31 | Skr45.00 Million ≈ $4.84 Million |
+2.27% |
| 2018-12-31 | Skr44.00 Million ≈ $4.74 Million |
-75.69% |
| 2017-12-31 | Skr181.00 Million ≈ $19.48 Million |
-9.50% |
| 2016-12-31 | Skr200.00 Million ≈ $21.52 Million |
+1.52% |
| 2015-12-31 | Skr197.00 Million ≈ $21.20 Million |
-31.12% |
| 2014-12-31 | Skr286.00 Million ≈ $30.78 Million |
-14.88% |
| 2013-12-31 | Skr336.00 Million ≈ $36.16 Million |
+409.09% |
| 2012-12-31 | Skr66.00 Million ≈ $7.10 Million |
-- |
About Creades AB Series A
Creades AB is a private equity and venture capital investment firm specializing in early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK50 million ($4.78 million) and SEK500 million ($47.91 million). Th… Read more